news
03-14-2024, 10:33 AM
In two early trials, blood cancer treatment appears promising for deadly brain tumor (https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZW FsdGgtbmV3cy90d28tZWFybHktdHJpYWxzLWJsb29kLWNhbmNl ci10cmVhdG1lbnQtYXBwZWFycy1wcm9taXNpbmctZGVhZGx5LW JyYWluLXJjbmExNDMyMTbSAQA?oc=5) NBC News
Intrathecal bivalent CAR T cells targeting EGFR and IL13R?2 in recurrent glioblastoma: phase 1 trial interim results (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvcz QxNTkxLTAyNC0wMjg5My160gEA?oc=5) Nature.com
Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors (https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmNubi5jb20vMjAyNC8wMy8xMy9oZW FsdGgvY2FyLXQtdGhlcmFweS1nbGlvYmxhc3RvbWEvaW5kZXgu aHRtbNIBT2h0dHBzOi8vYW1wLmNubi5jb20vY25uLzIwMjQvMD MvMTMvaGVhbHRoL2Nhci10LXRoZXJhcHktZ2xpb2JsYXN0b21h L2luZGV4Lmh0bWw?oc=5) CNN
“Dual-Target” cell therapy appears to shrink brain tumors (https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnBlbm5tZWRpY2luZS5vcmcvbmV3cy 9uZXdzLXJlbGVhc2VzLzIwMjQvbWFyY2gvZHVhbC10YXJnZXQt Y2VsbC10aGVyYXB5LWFwcGVhcnMtdG8tc2hyaW5rLWJyYWluLX R1bW9yc9IBAA?oc=5) Penn Medicine
Massachusetts clinical trial shows 'dramatic and rapid' progress against glioblastoma tumors (https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LndjdmIuY29tL2FydGljbGUvZ2xpb2 JsYXN0b21hLXR1bW9ycy1jYXItdC1jZWxsLXRoZXJhcHktbWFz cy1nZW5lcmFsLzYwMTkwNzI50gEA?oc=5) WCVB Boston
More... (https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZW FsdGgtbmV3cy90d28tZWFybHktdHJpYWxzLWJsb29kLWNhbmNl ci10cmVhdG1lbnQtYXBwZWFycy1wcm9taXNpbmctZGVhZGx5LW JyYWluLXJjbmExNDMyMTbSAQA?oc=5)
Intrathecal bivalent CAR T cells targeting EGFR and IL13R?2 in recurrent glioblastoma: phase 1 trial interim results (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvcz QxNTkxLTAyNC0wMjg5My160gEA?oc=5) Nature.com
Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors (https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmNubi5jb20vMjAyNC8wMy8xMy9oZW FsdGgvY2FyLXQtdGhlcmFweS1nbGlvYmxhc3RvbWEvaW5kZXgu aHRtbNIBT2h0dHBzOi8vYW1wLmNubi5jb20vY25uLzIwMjQvMD MvMTMvaGVhbHRoL2Nhci10LXRoZXJhcHktZ2xpb2JsYXN0b21h L2luZGV4Lmh0bWw?oc=5) CNN
“Dual-Target” cell therapy appears to shrink brain tumors (https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnBlbm5tZWRpY2luZS5vcmcvbmV3cy 9uZXdzLXJlbGVhc2VzLzIwMjQvbWFyY2gvZHVhbC10YXJnZXQt Y2VsbC10aGVyYXB5LWFwcGVhcnMtdG8tc2hyaW5rLWJyYWluLX R1bW9yc9IBAA?oc=5) Penn Medicine
Massachusetts clinical trial shows 'dramatic and rapid' progress against glioblastoma tumors (https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LndjdmIuY29tL2FydGljbGUvZ2xpb2 JsYXN0b21hLXR1bW9ycy1jYXItdC1jZWxsLXRoZXJhcHktbWFz cy1nZW5lcmFsLzYwMTkwNzI50gEA?oc=5) WCVB Boston
More... (https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZW FsdGgtbmV3cy90d28tZWFybHktdHJpYWxzLWJsb29kLWNhbmNl ci10cmVhdG1lbnQtYXBwZWFycy1wcm9taXNpbmctZGVhZGx5LW JyYWluLXJjbmExNDMyMTbSAQA?oc=5)